Delivery Order SPE2DB22D1106-SPE2DB24FEQE2

Award Date 5/5/24
Potential Completion Date 5/6/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a ceiling value of $1,215.88 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VASOSTRICT 20 UNIT/ML VIALML, a critical medication, with a period of performance through July 23, 2024. This order is placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,036.74 firm-fixed-price delivery order is for the provision of VASOSTRICT 20 UNIT/ML VIALML, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award, valued at $2,515.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under an Indefinite Delivery Contract (IDC), is for the supply of VASOSTRICT 20 UNIT/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024 and is a Firm Fixed Price arrangement. This award is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,569.99 Firm Fixed Price Delivery Order contract is for the delivery of VASOSTRICT 200 UNIT/10 ML VIAL 10ML medical supplies. The contract has an ultimate completion date of November 27, 2023 and was awarded on November 24, 2023. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,095.88 firm fixed price delivery order is for the supply of VASOSTRICT 20 UNIT/ML VIALML, a critical medical product, with a completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical product VASOSTRICT 200 UNIT/10 ML VIAL 10ML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $12,345.48 and a period of performance through April 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical worth up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,783.37 firm fixed-price delivery order is for the supply of VASOSTRICT 20 UNIT/ML VIALML, a pharmaceutical product, with a period of performance through January 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of VASOSTRICT 20 UNIT/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,036.75, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the...
This federal contract award is for the delivery of VASOSTRICT 20 UNIT/ML VIAL medical product to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, and does not have a set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025. This IDC serves as the primary vehicle for...
The federal contract award details a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VASOSTRICT 20 UNIT/ML VIALML. The $2,049.16 firm fixed-price contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEQE2
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VASOSTRICT 20 UNIT/ML VIAL to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,431.76 and an ultimate completion date of May 6, 2024. This is a delivery order contract with a firm fixed price pricing type.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award does not have a set-aside designation, indicating it was competed on a full and open basis. Amerisourcebergen's expertise in pharmaceutical distribution and its position as a major supplier to the federal government, particularly the Department of Defense and Veterans Affairs healthcare systems, have enabled the company to secure these high-value IDCs and individual contract awards.

Generated 8/4/24, 9:10 AM